Shane Eleniak - Feb 8, 2024 Form 4 Insider Report for CALIX, INC ((CALX))

Role: Chief Product Officer
Signature: /s/ Tom Gemetti as Attorney-in-fact for Shane Eleniak
Stock symbol: (CALX)
Transactions as of: Feb 8, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/12/2024, 06:05 PM
Previous filing: Feb 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	(CALX)	Stock Option (right to buy)	Award	$0	+109K		$0.00	109K	Feb 8, 2024	Common Stock	109K	$51.55	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 9, 2023, the reporting person was awarded a performance-based nonqualified stock option grant covering 200,000 shares of common stock. On February 8, 2024, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 54.5% of the grant had been achieved, resulting in a nonqualified stock option award of 109,000 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 8, 2024; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 8, 2024.

Content

On February 9, 2023, the reporting person was awarded a performance-based nonqualified stock option grant covering 200,000 shares of common stock. On February 8, 2024, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 54.5% of the grant had been achieved, resulting in a nonqualified stock option award of 109,000 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 8, 2024; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 8, 2024.